Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 06:00 ET | Source: CervoMed Inc.

CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis

CervoMed's neflamapimod has been selected for the U.K.’s EXPERTS-ALS platform to rapidly evaluate it in ALS